A 34-year-old patient with schizophrenia requires treatment…

A 34-yeаr-оld pаtient with schizоphreniа requires treatment with a secоnd-generation antipsychotic. The patient has obesity, dyslipidemia, and a strong family history of type 2 diabetes. After reviewing the patient's medical history and baseline ECG, the PMHNP wants to select an antipsychotic associated with a relatively low risk of weight gain and metabolic adverse effects. Which medication is the most appropriate choice based on this consideration?